Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP671178.RAVjmTI0_w0FNfv9aseCSd2IZs9OiqgEUc8kmMyPkHv1g130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671178.RAVjmTI0_w0FNfv9aseCSd2IZs9OiqgEUc8kmMyPkHv1g130_provenance.
• NP865099.RAAmOAyIRXwjwe54bNo9kFr57cMJ8KwNbrqh1Vxbfn_s4130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865099.RAAmOAyIRXwjwe54bNo9kFr57cMJ8KwNbrqh1Vxbfn_s4130_provenance.
• NP452197.RAr0y2sO5eRaW2UOY_rO0TBlyW_-5TI1D543QIkVNDIvU130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452197.RAr0y2sO5eRaW2UOY_rO0TBlyW_-5TI1D543QIkVNDIvU130_provenance.
• NP349588.RACPs4EhViLCPcI-BOKItDWaMV6LfQEPlZIiyE6ofYlHY130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349588.RACPs4EhViLCPcI-BOKItDWaMV6LfQEPlZIiyE6ofYlHY130_provenance.
• NP304381.RAXIIW-Ji3KK-o-gs3nzt5fx7V14O70xCOnMhW6RAzD1M130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304381.RAXIIW-Ji3KK-o-gs3nzt5fx7V14O70xCOnMhW6RAzD1M130_provenance.
• NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_provenance.
• NP746123.RA9c0WTEwyD2rJOUsKtzmlYM3IyTrZ7xNJd34GggK3MSY130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746123.RA9c0WTEwyD2rJOUsKtzmlYM3IyTrZ7xNJd34GggK3MSY130_provenance.
• NP744597.RAoWPDAP4E5HpsMoWNVntZKgbues5aCCxbQGIxLO53RVg130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744597.RAoWPDAP4E5HpsMoWNVntZKgbues5aCCxbQGIxLO53RVg130_provenance.
• NP320407.RA8ew7vkYQD18md3rPjzQ24chuJXKtUuAEZecyonxFzVI130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320407.RA8ew7vkYQD18md3rPjzQ24chuJXKtUuAEZecyonxFzVI130_provenance.
• NP656908.RAIt27d_Wg44OwmHMJdiJbWOC7rFyZeB-VM8OC2OJA9Bw130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656908.RAIt27d_Wg44OwmHMJdiJbWOC7rFyZeB-VM8OC2OJA9Bw130_provenance.
• NP598290.RADu_OmASBfkCLLC9TIXvgy2kXGjOcsXT_iUIkHpMt0uU130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598290.RADu_OmASBfkCLLC9TIXvgy2kXGjOcsXT_iUIkHpMt0uU130_provenance.
• NP598296.RAAw6mjOVAx2u5K4s7U7IF6EBrKZ08tSUtO1y62gnVwpQ130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598296.RAAw6mjOVAx2u5K4s7U7IF6EBrKZ08tSUtO1y62gnVwpQ130_provenance.
• NP303064.RA076VlLsm3xFkP28cHc2fukJGtH7AB7Otatw_NsLHm9I130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303064.RA076VlLsm3xFkP28cHc2fukJGtH7AB7Otatw_NsLHm9I130_provenance.
• NP608228.RA62YJpHCcdSoB9XYjaHEICrgLFjjSeBubWOdDutL2ICk130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608228.RA62YJpHCcdSoB9XYjaHEICrgLFjjSeBubWOdDutL2ICk130_provenance.
• NP608229.RAy7cRccIiR3PPPs6zaUcJLHXIKFWIfaGB_IzUn8KObE8130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608229.RAy7cRccIiR3PPPs6zaUcJLHXIKFWIfaGB_IzUn8KObE8130_provenance.
• assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP302207.RApbKe5DhR6U-eSRjiVPr5T7D9m8dszDYzCpXl7fN8ezQ130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302207.RApbKe5DhR6U-eSRjiVPr5T7D9m8dszDYzCpXl7fN8ezQ130_provenance.
• NP302225.RAskPvN17iHytUmaxshiK_xXChOiZWOfUXHxhG2jUld3k130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302225.RAskPvN17iHytUmaxshiK_xXChOiZWOfUXHxhG2jUld3k130_provenance.
• NP303057.RAl0zy47so9EvTyxh8L4fPTVQ_b-EsBIGNZCyvCBwC3z4130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303057.RAl0zy47so9EvTyxh8L4fPTVQ_b-EsBIGNZCyvCBwC3z4130_provenance.
• NP598298.RAIiU1FnrSM3T8ToRe0br7n5vLrW2g-J-x2d5DDcxOdNo130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598298.RAIiU1FnrSM3T8ToRe0br7n5vLrW2g-J-x2d5DDcxOdNo130_provenance.
• NP598289.RArr8bADlXACHURBmuzm2yMM4ilPNUTiyS7ZX3LPL3Jzg130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598289.RArr8bADlXACHURBmuzm2yMM4ilPNUTiyS7ZX3LPL3Jzg130_provenance.
• NP598291.RAuMZyPaxwmffLf5oxUHDZQhui7pYWiikrC5cTVZ1ghK0130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598291.RAuMZyPaxwmffLf5oxUHDZQhui7pYWiikrC5cTVZ1ghK0130_provenance.
• NP598292.RAvctZFl9R7H7YQ8jcuzeBZvF5QKLi2mu3h6F0ifVjgfY130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598292.RAvctZFl9R7H7YQ8jcuzeBZvF5QKLi2mu3h6F0ifVjgfY130_provenance.